Research view
Switch to patient viewLewy body dementia: trials that stopped early
Trials on Lewy body dementia that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
3 stopped trials give a reason in the registry, latest registry update first.
Terminated
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
Reason given in the registry “Interim analysis was performed for 442 patients who completed Part I of the PROSEEK study-(CLR\_18\_06); it did not show evidence of treatment benefit in patients receiving Vodobatinib.”
Quoted unchanged from ClinicalTrials.gov; record updated 8 Jun 2026.
- Ended
- Apr 2024
- Phase
- Phase 2
- Run by
- Georgetown University
- Registry record
- NCT03996460
Withdrawn
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
Reason given in the registry “Study withdrawn and being modified under another protocol”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2022.
- Ended
- Dec 2024
- Run by
- Mayo Clinic
- Registry record
- NCT05497817
Withdrawn
Biomarkers in Neurodegenerative Diseases
Reason given in the registry “Lack of regulatory approval”
Quoted unchanged from ClinicalTrials.gov; record updated 12 Nov 2019.
- Ended
- Oct 2025
- Run by
- University of Minnesota
- Registry record
- NCT04055532
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.